Management of Thyroid Nodules and Pulmonary Findings

Thyroid Nodule Management

• The American College of Radiology recommends fine needle aspiration (FNA) for TI-RADS 3 nodules only if they are ≥1.5 cm, with follow-up ultrasound in 6-12 months for smaller nodules 1, 4
• Thyroid function tests should be performed to assess the functional status of the nodules, as recommended by the American College of Radiology 4

Pulmonary Nodule Management

• The British Thoracic Society guidelines recommend follow-up CT in 3-6 months for subcentimeter pulmonary nodules, with volume doubling time (VDT) calculation as the preferred method to assess growth 2
• A ≥25% volume change defines significant growth that may warrant further investigation, according to the British Thoracic Society guidelines 2

Mediastinal Lymph Node Evaluation

• Mediastinal lymph nodes measuring 13mm are at the upper limit of normal size, and should be monitored on the same follow-up chest CT recommended for the pulmonary nodules, as suggested by the American College of Radiology 1, 5

Integrated Approach

• The American College of Radiology recommends performing thyroid function tests and scheduling follow-up ultrasound in 6-12 months for TI-RADS 3 nodules, unless they are ≥1.5 cm 1, 4
• For pulmonary findings, the British Thoracic Society guidelines recommend scheduling follow-up chest CT in 3-6 months, with volumetric analysis to assess for growth 2

Special Considerations

• The British Thoracic Society guidelines suggest that if the patient has a history of prior malignancy, more aggressive evaluation may be warranted 2
• The presence of both thyroid nodules and pulmonary nodules does not automatically indicate metastatic disease, as both findings are common in the general population, according to the American College of Radiology and the British Thoracic Society guidelines 1, 2